Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Sharkey

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Nuclear Medicine Communications|September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodiesT M Behr, M E Juweid, R M Sharkey, et al.
Cancer Research|December 1, 1995
Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigenM Juweid, R M Sharkey, T Behr, et al.
Cancer|July 1, 1996
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2M Juweid, R M Sharkey, T M Behr, et al.
Cancer|September 1, 1979
Carcinoembryonic antigen in carcinoma of the uterine cervix. 2. Tissue localization and correlation with plasma antigen concentrationJ R van Nagell, E S Donaldson, E C Gay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Rat adjuvant arthritis: imaging with technetium-99m-anti-CD4 Fab' fragmentsR W Kinne, W Becker, T Koscheck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1996
Reduction of renal uptake of monoclonal antibody fragments by amino acid infusionT M Behr, W S Becker, R M Sharkey, et al.
Cancer|February 1, 1994
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomasR M Sharkey, D M Goldenberg, R Vagg, et al.
Cancer Research|December 1, 1995
Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibodyM Juweid, R M Sharkey, A Markowitz, et al.
Cancer|March 15, 1993
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14R M Sharkey, D M Goldenberg, S Murthy, et al.
Bioconjugate Chemistry|November 1, 1991
Technetium labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2K E Linder, M D Wen, D P Nowotnik, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Nuclear Medicine Communications|September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodiesT M Behr, M E Juweid, R M Sharkey, et al.
Cancer Research|December 1, 1995
Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigenM Juweid, R M Sharkey, T Behr, et al.
Cancer|July 1, 1996
Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2M Juweid, R M Sharkey, T M Behr, et al.
Cancer|September 1, 1979
Carcinoembryonic antigen in carcinoma of the uterine cervix. 2. Tissue localization and correlation with plasma antigen concentrationJ R van Nagell, E S Donaldson, E C Gay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Rat adjuvant arthritis: imaging with technetium-99m-anti-CD4 Fab' fragmentsR W Kinne, W Becker, T Koscheck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1996
Reduction of renal uptake of monoclonal antibody fragments by amino acid infusionT M Behr, W S Becker, R M Sharkey, et al.
Cancer|February 1, 1994
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomasR M Sharkey, D M Goldenberg, R Vagg, et al.
Cancer Research|December 1, 1995
Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibodyM Juweid, R M Sharkey, A Markowitz, et al.
Cancer|March 15, 1993
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14R M Sharkey, D M Goldenberg, S Murthy, et al.
Bioconjugate Chemistry|November 1, 1991
Technetium labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2K E Linder, M D Wen, D P Nowotnik, et al.
Pageof 15